Kevin Brosseau is seeking to stem the flow of a deadly opioid not only to reverse U.S. tariffs but to end domestic drug deaths.
CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...
New guidelines around involuntary care are receiving criticism from those who advocate for drug users and their families ...
This milestone marks a significant step forward in Rakovina’s mission to accelerate drug discovery using advanced AI-driven platforms. In September 2024, Rakovina announced its partnership with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results